<?xml version="1.0" encoding="UTF-8"?>
<adverse_event_case case_number="3008281">
  <adverse_event_report>
    <yyqq>97Q4</yyqq>
    <isr>3011625</isr>
    <initial_followup_code>I</initial_followup_code>
    <followup_sequence></followup_sequence>
    <image>3011625-2</image>
    <event_date>1997-09-09</event_date>
    <manufacturer_date>1997-09-10</manufacturer_date>
    <fda_date>1997-11-03</fda_date>
    <report_code>PER</report_code>
    <manufacturer_number>US97092296A</manufacturer_number>
    <manufacturer_sending>Eli Lilly And Company</manufacturer_sending>
    <age>35.0</age>
    <age_units>YR</age_units>
    <gender>M</gender>
    <is_electronic_submission>false</is_electronic_submission>
    <weight></weight>
    <weight_units></weight_units>
    <report_date></report_date>
    <reporter_occupation></reporter_occupation>
    <death_date></death_date>
    <manufacturer_notified>false</manufacturer_notified>
    <confidentiality_status>false</confidentiality_status>
    <reporter_country></reporter_country>
    <outcome outcome_code="HO"/>
    <reaction reaction_preferred_term="Condition Aggravated"/>
    <reaction reaction_preferred_term="Delusion Nos"/>
    <reaction reaction_preferred_term="Drug Withdrawal Syndrome"/>
    <report_source report_source_code="SDY"/>
    <report_source report_source_code="HP"/>
    <drug_datum>
      <drug_sequence>1000026276</drug_sequence>
      <role_code>PS</role_code>
      <drug_name>Zyprexa</drug_name>
      <validated_or_verbatim>1</validated_or_verbatim>
      <administration_route>ORAL</administration_route>
      <dechallenge_code>D</dechallenge_code>
      <rechallenge_code>D</rechallenge_code>
      <lot_number></lot_number>
      <expiration_date></expiration_date>
      <nda_number></nda_number>
      <therapy>
        <start_date>1997-09-03</start_date>
        <end_date>1997-09-09</end_date>
        <duration></duration>
        <duration_units></duration_units>
      </therapy>
    </drug_datum>
  </adverse_event_report>
  <adverse_event_report>
    <yyqq>98Q1</yyqq>
    <isr>3092222</isr>
    <initial_followup_code>F</initial_followup_code>
    <followup_sequence>2</followup_sequence>
    <image>3092222-X</image>
    <event_date>1997-09-09</event_date>
    <manufacturer_date>1997-11-11</manufacturer_date>
    <fda_date>1998-01-30</fda_date>
    <report_code>PER</report_code>
    <manufacturer_number>US97092296A</manufacturer_number>
    <manufacturer_sending>Eli Lilly And Company Lilly Corporate Center</manufacturer_sending>
    <age>35.0</age>
    <age_units>YR</age_units>
    <gender>M</gender>
    <is_electronic_submission>false</is_electronic_submission>
    <weight></weight>
    <weight_units></weight_units>
    <report_date></report_date>
    <reporter_occupation></reporter_occupation>
    <death_date></death_date>
    <manufacturer_notified>false</manufacturer_notified>
    <confidentiality_status>false</confidentiality_status>
    <reporter_country></reporter_country>
    <outcome outcome_code="HO"/>
    <reaction reaction_preferred_term="Delusion Nos"/>
    <reaction reaction_preferred_term="Hallucination Nos"/>
    <report_source report_source_code="SDY"/>
    <report_source report_source_code="HP"/>
    <drug_datum>
      <drug_sequence>1000191957</drug_sequence>
      <role_code>PS</role_code>
      <drug_name>Zyprexa</drug_name>
      <validated_or_verbatim>1</validated_or_verbatim>
      <administration_route>ORAL</administration_route>
      <dechallenge_code>D</dechallenge_code>
      <rechallenge_code>D</rechallenge_code>
      <lot_number></lot_number>
      <expiration_date></expiration_date>
      <nda_number></nda_number>
      <therapy>
        <start_date>1997-09-03</start_date>
        <end_date>1997-09-09</end_date>
        <duration></duration>
        <duration_units></duration_units>
      </therapy>
    </drug_datum>
  </adverse_event_report>
</adverse_event_case>
